Buy & Sell Sanofi SA (SNY) – Sanofi SA Price Today
Aura AI Summary
Key Stats
- $102.23BMarket Cap
- HealthSector
- -12.82%3M Drawdown
- $119.22BEnterprise Value
- 5.71%Dividend Yield
- 32% Buy | 68% SellTrading Activity
- 93 daysTypical Hold Time
Sanofi SA (SNY) is currently valued at a market capitalization of $102.23B, with an enterprise value of $119.22B. Over the past 52 weeks, Sanofi SA has traded between a low of $42.42 and a high of $52.9, highlighting its annual price range. Over the past three months, Sanofi SA has recorded a drawdown of -12.82%, reflecting recent price volatility. Sanofi SA offers a dividend yield of 5.71%, with the most recent dividend of $2.42 paid on 04 May 26. On average, investors hold Sanofi SA for approximately 93 days, indicating typical investor behavior on the platform.
About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Most Recent News
Calix faces investigation over possible securities law violations after Q1 earnings miss and share price drop.
Calix, Inc. is under investigation by law firm Kirby McInerney LLP for potential violations of federal securities laws following its Q1 2026 earnings report. The company reported a decline in non-GAAP gross margin and issued cautious guidance for the...
Investigation launched into Zillow over possible securities law violations amid revenue and legal issues
Kirby McInerney LLP is investigating Zillow Group for potential violations of federal securities laws related to premature revenue recognition and an alleged unlawful agreement with Redfin. Zillow's stock dropped following reports of revenue recognit...
Roundhill Innovation-100 0DTE ETF offers 27.1% yield but faces NAV erosion risks from over-distribution.
The Roundhill Innovation-100 0DTE Covered Call Strategy ETF (QDTE) provides a high distribution yield of 27.1%, generated through 0DTE call writing on a synthetic Nasdaq portfolio. Since its inception, QDTE has delivered competitive and sometimes sup...
